Roger B. Dodd

3.1k total citations
22 papers, 1.5k citations indexed

About

Roger B. Dodd is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Roger B. Dodd has authored 22 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Immunology. Recurrent topics in Roger B. Dodd's work include Glycosylation and Glycoproteins Research (4 papers), Alzheimer's disease research and treatments (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Roger B. Dodd is often cited by papers focused on Glycosylation and Glycoproteins Research (4 papers), Alzheimer's disease research and treatments (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Roger B. Dodd collaborates with scholars based in United Kingdom, Canada and United States. Roger B. Dodd's co-authors include Kurt Drickamer, Paul J. Lehner, Lidia M. Duncan, Russell Wallis, J. Paul Luzio, Siân C. Piper, Mark K. Saville, Simon Hoer, Peter St George‐Hyslop and Seema Qamar and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Roger B. Dodd

21 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger B. Dodd United Kingdom 14 845 587 195 190 184 22 1.5k
René J. P. Musters Netherlands 13 632 0.7× 359 0.6× 240 1.2× 185 1.0× 155 0.8× 19 1.6k
Richard F. Collins Canada 17 855 1.0× 416 0.7× 272 1.4× 511 2.7× 84 0.5× 23 1.7k
Ayesha Murshid United States 26 1.5k 1.8× 546 0.9× 238 1.2× 563 3.0× 142 0.8× 43 2.1k
Serge Urbach France 25 1.4k 1.7× 169 0.3× 106 0.5× 277 1.5× 213 1.2× 66 2.1k
Liliana Busconi United States 25 987 1.2× 787 1.3× 574 2.9× 278 1.5× 100 0.5× 40 2.4k
Daniel Wong United Kingdom 15 797 0.9× 605 1.0× 78 0.4× 63 0.3× 139 0.8× 20 1.7k
Dean Clift United Kingdom 17 1.1k 1.4× 290 0.5× 103 0.5× 481 2.5× 175 1.0× 21 1.7k
Ali Khoshnan United States 20 714 0.8× 430 0.7× 86 0.4× 80 0.4× 156 0.8× 27 1.6k
Wade Edris United States 17 1.0k 1.2× 269 0.5× 92 0.5× 128 0.7× 236 1.3× 31 1.5k
Pushkar Sharma India 22 678 0.8× 161 0.3× 127 0.7× 294 1.5× 222 1.2× 45 1.6k

Countries citing papers authored by Roger B. Dodd

Since Specialization
Citations

This map shows the geographic impact of Roger B. Dodd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger B. Dodd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger B. Dodd more than expected).

Fields of papers citing papers by Roger B. Dodd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger B. Dodd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger B. Dodd. The network helps show where Roger B. Dodd may publish in the future.

Co-authorship network of co-authors of Roger B. Dodd

This figure shows the co-authorship network connecting the top 25 collaborators of Roger B. Dodd. A scholar is included among the top collaborators of Roger B. Dodd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger B. Dodd. Roger B. Dodd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Schindler, Christina, Roger B. Dodd, Lisa Bamber, et al.. (2023). A simeprevir-inducible molecular switch for the control of cell and gene therapies. Nature Communications. 14(1). 7753–7753. 8 indexed citations
3.
Hurt, Elaine M., Suneetha B. Thomas, Kathy Mulgrew, et al.. (2021). Abstract 1828: AZD8853: A novel antibody targeting GDF15 for immunotherapy refractory tumors. Cancer Research. 81(13_Supplement). 1828–1828. 2 indexed citations
4.
Dodd, Roger B., Darren J. Schofield, Trevor Wilkinson, & Zachary T. Britton. (2020). Generating therapeutic monoclonal antibodies to complex multi-spanning membrane targets: Overcoming the antigen challenge and enabling discovery strategies. Methods. 180. 111–126. 10 indexed citations
5.
Dodd, Roger B., Trevor Wilkinson, & Darren J. Schofield. (2018). Therapeutic Monoclonal Antibodies to Complex Membrane Protein Targets: Antigen Generation and Antibody Discovery Strategies. BioDrugs. 32(4). 339–355. 31 indexed citations
6.
Dodd, Roger B.. (2018). An exTREMe disruption in Alzheimer's cleanup. Journal of Biological Chemistry. 293(32). 12647–12648. 1 indexed citations
7.
Thornton, Peter, Jean Sévalle, Michael J. Deery, et al.. (2017). TREM 2 shedding by cleavage at the H157‐S158 bond is accelerated for the Alzheimer's disease‐associated H157Y variant. EMBO Molecular Medicine. 9(10). 1366–1378. 127 indexed citations
8.
Burr, Stephen P., Ana S.H. Costa, Guinevere L. Grice, et al.. (2016). Mitochondrial Protein Lipoylation and the 2-Oxoglutarate Dehydrogenase Complex Controls HIF1α Stability in Aerobic Conditions. Cell Metabolism. 24(5). 740–752. 120 indexed citations
9.
Böhm, Christopher, F. Chen, Jean Sévalle, et al.. (2015). Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways. Molecular and Cellular Neuroscience. 66(Pt A). 3–11. 50 indexed citations
10.
Li, Yi, Christopher Böhm, Roger B. Dodd, et al.. (2014). Structural biology of presenilin 1 complexes. Molecular Neurodegeneration. 9(1). 59–59. 35 indexed citations
11.
Li, Yi, Ching‐Ju Tsai, Christopher Böhm, et al.. (2013). Structural Interactions between Inhibitor and Substrate Docking Sites Give Insight into Mechanisms of Human PS1 Complexes. Structure. 22(1). 125–135. 53 indexed citations
12.
Manolaridis, Ioannis, Kiran Kulkarni, Roger B. Dodd, et al.. (2013). Mechanism of farnesylated CAAX protein processing by the intramembrane protease Rce1. Nature. 504(7479). 301–305. 134 indexed citations
13.
Yang, Jing, Kiran Kulkarni, Ioannis Manolaridis, et al.. (2011). Mechanism of Isoprenylcysteine Carboxyl Methylation from the Crystal Structure of the Integral Membrane Methyltransferase ICMT. Molecular Cell. 44(6). 997–1004. 42 indexed citations
14.
Duncan, Lidia M., Siân C. Piper, Roger B. Dodd, et al.. (2006). Lysine‐63‐linked ubiquitination is required for endolysosomal degradation of class I molecules. The EMBO Journal. 25(8). 1635–1645. 227 indexed citations
15.
Lehner, Paul J., Simon Hoer, Roger B. Dodd, & Lidia M. Duncan. (2005). Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases. Immunological Reviews. 207(1). 112–125. 110 indexed citations
16.
McCullough, Jeffrey, et al.. (2004). White particulate matter: report of the ad hoc industry review group. Transfusion. 44(7). 1112–1118. 2 indexed citations
17.
Dodd, Roger B., Mark D. Allen, Stephanie E. Brown, et al.. (2004). Solution Structure of the Kaposi's Sarcoma-associated Herpesvirus K3 N-terminal Domain Reveals a Novel E2-binding C4HC3-type RING Domain. Journal of Biological Chemistry. 279(51). 53840–53847. 83 indexed citations
18.
Dodd, Roger B. & Kurt Drickamer. (2001). Lectin-like proteins in model organisms: implications for evolution of carbohydrate-binding activity. Glycobiology. 11(5). 71R–79R. 306 indexed citations
19.
Wallis, Russell & Roger B. Dodd. (2000). Interaction of Mannose-binding Protein with Associated Serine Proteases. Journal of Biological Chemistry. 275(40). 30962–30969. 78 indexed citations
20.
Drickamer, Kurt & Roger B. Dodd. (1999). C-Type lectin-like domains in Caenorhabditis elegans: predictions from the complete genome sequence. Glycobiology. 9(12). 1357–1369. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026